肥厚型心肌病患者埋藏式心脏自动复律除颤器(ICD)植入后的长期生存率和风险

肥厚型心肌病是最常见的一种心肌病，而心脏性猝死是肥厚型心肌病患者的首位死因。埋藏式心脏自动复律除颤器（ICD）作为一种最有效的治疗手段被推荐用于改善猝死高危患者的长期生存率。但是，尽管埋藏式心脏自动复律除颤器在肥厚型心肌病患者猝死预防方面起到了不可否定的作用，但术后不良事件及进展性心力衰竭的风险居高不下，导致了部分植入ICD的患者预后改善不理想，引人深思，笔者就次做一综述。

The Long-Term Survival and the Risks of lmplantable Cardioverter Defibrillators Recipients with Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy （HCM） is one of the most common cardiomyopathy and sudden cardiac death（SCD） is the leading cause of death in this population. Implantable cardioverter defibrillators （ICDs） are routinely recommended to those patients at high-risk of SCD to improve survival. Despite of the irreplaceable role in prevention of SCD, the high incidence of implant-related complications, adverse events and progressing of heart failure result in poor improvement in long-term cardiovascular mortality in ICD recipients.